Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 307 across all filing types
Latest filing 2026-02-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients. This type of disclosure regarding capital structure and equity-based compensation, filed with financial authorities, falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure that does not fit into the other specialized categories like DIRS (which is for individual director dealings) or SHA (which is for general share issues).
2026-02-12 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically an amendment ('정정신고') to a previous filing. It details changes to stock option grants, including the number of shares and the list of recipients. In the context of financial filings, announcements regarding stock option grants, capital changes, or equity-based compensation adjustments that do not fit into specific categories like 'Director's Dealing' or 'Remuneration' are classified under general regulatory filings.
2026-02-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Lunit. It details the date, location, and specific agenda items for the upcoming 13th Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2026-02-12 Korean
전환가액의조정 (제1회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from Lunit regarding the adjustment of the conversion price for its 1st series convertible bonds due to a decline in market price. This type of disclosure, which details changes to capital structure instruments (convertible bonds), falls under the category of capital and financing updates.
2026-02-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 1% confidence The document is a regulatory filing from a Korean company (Lunit) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard disclosure requirement for listed companies in Korea (KRX) to report preliminary financial results before the final audited annual report is published. Since it provides key financial highlights and reasons for the variance, it falls under the 'Earnings Release' category.
2026-01-30 Korean
단기차입금증가결정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory announcement regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, purpose (operating funds), and board approval date. This falls under financing activities and capital structure changes, which aligns with the 'CAP' (Capital/Financing Update) category.
2026-01-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.